-Nabi Genmed development focus on non-viral vector for gene transduction system which involves gene delivery by nano-materials, polymer materials and lipsome vectors. We research, identify, optimize and develop such non-viral vectors and highly efficacious gene drug with non-toxicity profiles.
-With the limited efficacy and debilitating toxic effects of conventional cancer treatments, NG's non-toxicity approach and novel therapeutic pathway to cancer treatment will draw global interest. Our product candidates are designed to address unmet medical need in cancer treatment without harming normal cells. Because of thoroughness of solving tumors, non-toxicity, and use in combination with chemotherapy, radiaotherapy and surgery, oncologists, surgeons and radiotherapists utilize NG's products to treat a wide range of solid tumors.
-NG invest in discovery and development of a variety of molecular therapies, oncology, fermentation, purification and nano technologies for the drug candidates.
-Our business strategy is to build investors value by discovering therapeutic candidates and advancing them to clinic validation.
-With the limited efficacy and debilitating toxic effects of conventional cancer treatments, NG's non-toxicity approach and novel therapeutic pathway to cancer treatment will draw global interest. Our product candidates are designed to address unmet medical need in cancer treatment without harming normal cells. Because of thoroughness of solving tumors, non-toxicity, and use in combination with chemotherapy, radiaotherapy and surgery, oncologists, surgeons and radiotherapists utilize NG's products to treat a wide range of solid tumors.
-NG invest in discovery and development of a variety of molecular therapies, oncology, fermentation, purification and nano technologies for the drug candidates.
-Our business strategy is to build investors value by discovering therapeutic candidates and advancing them to clinic validation.
NABI
GENMED
ABOUT NABI GENMED
